Zacks Small-Cap Research has set a price valuation of $4.50 for X4 Pharmaceuticals. This valuation may influence investors' perception of the stock's value and potentially impact its price in the short term. However, it is important to note that price targets are not guarantees and can be influenced by various factors, including market conditions and company performance.